Page 3 - கலைக்கழகம் ஆஃப் நிர்வகிக்கப்பட்டது பராமரிப்பு மருந்தகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article EAGAN, Minn., April 7, 2021 /PRNewswire/ Armed with insights from substantive, real-world data, Blue Cross and Blue Shield plans that partner with Prime Therapeutics LLC (Prime) are now more effectively making data-driven decisions to mitigate the high costs of autoimmune therapies for inflammatory conditions and multiple sclerosis (MS). Recently, Prime analyzed integrated pharmacy and medical claims data for specialty drug use in autoimmune conditions – the top cost drivers among all drug health care expenses. At 22% of all drug expenditures through the medical and pharmacy benefits among Prime s commercially insured book of business, autoimmune therapy costs for inflammatory conditions and MS account for $6.7 billion annually.

Jenine andersonCatherine starnerSarah taylorAcademy of managed care pharmacyDrug administrationBlue crossBlue shieldPrime therapeuticsBlue plansManaged care pharmacyVirtual annual meeting aprilBlue shield plansஜெனின் ஆண்டர்சன்கேத்தரின் ஸ்டார்னர்சாரா டெய்லர்கலைக்கழகம் ஆஃப் நிர்வகிக்கப்பட்டது பராமரிப்பு மருந்தகம்